Clinical Trial Update: Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After Surgery [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing Qutenza 8% capsaicin patch with a low-dose capsaicin treatment for postoperative neuropathic pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Neuropathic Pain

Drugs mentioned

• Capsaicin (low-dose) (capsaicin)
• QUTENZA (Capsaicin)

Snippet

Sponsor: Averitas Pharma, Inc. | Conditions: Post Surgical Neuropathic Pain | Phase 3 | Status: COMPLETED